Rapid Immune Tests SARS-COV-2 – An Experience in Beira Baixa

Introduction: SARS-CoV-2 affects the epithelial cells of the respiratory tract, causing severeinfections. Since it is a pathology with a high level of transmissibility, it becomes central to masstesting. In addition, there was also a need to monitor the epidemic through serological tests.Objective: Evaluate the presence of antibodies against SARS-CoV-2 in the community residing in‘International Seven Journal of Health, São José dos Pinhais, v.1, n.2. p. 28-36, jul./aug., 2022 29Beira Baixa through immunological screening tests. Materials and methods: Analytical, crosssectional, and observational study, whose sample consists of 206 individuals. Data collection tookplace between February and April 2021, in the laboratories of the Dr. Lopes Dias Higher Schoolof Health. Verbal informed consent, a questionnaire to collect sociodemographic data and theserological test were applied. Results: Of the total number of participants, 15.5% admitted tohaving had COVID-19, of which 0.5% suspected they had been infected and 84% said they hadnever been infected. Regarding the presence of antibodies, 2.9% of the tests performed werepositive for the presence of IgM's while 30.1% were positive for the presence of IgG's. Regardingvaccination, at the time of the investigation only 10.2% of the participants were vaccinated, ofwhich 9.7% had IgG antibodies. Conclusion: Rapid serological tests can provide information aboutthe presence of antibodies to SARS-CoV-2, thus being a very advantageous tool for immunity